Maven Securities LTD - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Maven Securities LTD ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q1 2023$165,500
+347.3%
50,000
+233.3%
0.00%
+200.0%
Q3 2022$37,000
-96.0%
15,000
-96.8%
0.00%
-96.4%
Q2 2022$929,000
-85.5%
469,206
-86.6%
0.03%
-87.4%
Q1 2022$6,389,000
+36.7%
3,491,524
+5.3%
0.22%
+65.7%
Q4 2021$4,675,000
+253.9%
3,315,607
+341.9%
0.13%
+127.1%
Q1 2021$1,321,000750,3250.06%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 8,793,321$32,447,35411.70%
Velan Capital Investment Management LP 2,726,051$10,059,1289.34%
Altium Capital Management LP 2,380,000$8,782,2006.65%
AWM Investment Company, Inc. 6,017,572$22,204,8413.01%
Caligan Partners LP 847,513$3,127,3231.76%
Perceptive Advisors 11,900,255$43,911,9411.27%
Mesirow Financial Investment Management, Inc. 51,686$190,7210.81%
OBERWEIS ASSET MANAGEMENT INC/ 1,668,700$6,157,5030.75%
TANG CAPITAL MANAGEMENT LLC 1,260,000$4,649,4000.68%
EAM Investors, LLC 883,842$3,261,3770.60%
View complete list of ADMA BIOLOGICS INC shareholders